2019
DOI: 10.1007/s00234-019-02202-3
|View full text |Cite
|
Sign up to set email alerts
|

Gray matter reduction related to decreased serum creatinine and increased triglyceride, Hemoglobin A1C, and low-density lipoprotein in subjects with obesity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
10
0
2

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 38 publications
4
10
0
2
Order By: Relevance
“…The diffuse and uniform nature of the BMI‐related brain alterations may be more congruent with cortical thinning as a consequence of obesity. The negative effects of BMI on brain structure are supported by a Mendelian randomization study, 40 several longitudinal studies, demonstrating that obesity or obesity‐related metabolic alterations precede and accelerate brain changes over time 18,41 and by improvement of brain indices following a successful treatment of obesity 42–44 …”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…The diffuse and uniform nature of the BMI‐related brain alterations may be more congruent with cortical thinning as a consequence of obesity. The negative effects of BMI on brain structure are supported by a Mendelian randomization study, 40 several longitudinal studies, demonstrating that obesity or obesity‐related metabolic alterations precede and accelerate brain changes over time 18,41 and by improvement of brain indices following a successful treatment of obesity 42–44 …”
Section: Discussionmentioning
confidence: 98%
“…Obesity may represent a risk factor for neuroprogression in BD which can be modified or managed. Obesity‐related cortical alterations might be preventable or even reversible through weight management by dietary, lifestyle, surgical, or pharmacological interventions 42–44 . Furthermore, the current psychiatric medications have a very limited range of pharmacodynamic properties and the number of mechanistically different medications is proportional to efficacy in managing severe, multifactorial disorders.…”
Section: Discussionmentioning
confidence: 99%
“…If obesity leads to brain alterations, this represents a manageable/modifiable risk factor for neuroprogressive BD [ 75 ]. Obesity-related structural brain abnormalities might be preventable or even reversible with dietary/lifestyle/surgical interventions focused on weight management [ 76 78 ]. Also, medications targeting obesity, such as liraglutide, may have neuroprotective effects, as also documented in participants with BD [ 79 ].…”
Section: Discussionmentioning
confidence: 99%
“…This finding is consistent with our previous meta-analysis providing strong evidence that obesity is associated with lower grey matter density in brain regions involved in cognition and emotional regulation [ 28 ]. If the mechanisms underlying the link between obesity and reductions in grey matter volume measured by MRI remain largely unknown, recent evidence indicates that visceral obesity-related metabolic alterations, including insulin resistance, dyslipidemia, and low-grade chronic inflammation, might mediate the link between obesity and brain abnormalities [ 64 , 65 ]. Moreover, brain alterations observed in individuals with obesity may also involve chronic inflammation, increased oxidative stress or cellular autophagy associated with obesity [ 66 ].…”
Section: Discussionmentioning
confidence: 99%